These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21586100)

  • 1. Effect of erythropoietin therapy on clinical outcome in patients after acute ischemic stroke: a debatable issue.
    Yuen CM; Sun CK; Leu S; Yip HK
    Crit Care; 2011; 15(3):425. PubMed ID: 21586100
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin for stroke treatment: dead or alive?
    Minnerup J; Wersching H; Schäbitz WR
    Crit Care; 2011; 15(2):129. PubMed ID: 21418552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke.
    Yip HK; Tsai TH; Lin HS; Chen SF; Sun CK; Leu S; Yuen CM; Tan TY; Lan MY; Liou CW; Lu CH; Chang WN
    Crit Care; 2011; 15(1):R40. PubMed ID: 21269484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human choriogonadotropin and epoetin alfa in acute ischemic stroke patients (REGENESIS-LED trial).
    Cramer SC; Hill MD;
    Int J Stroke; 2014 Apr; 9(3):321-7. PubMed ID: 24588854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A truncated erythropoietin receptor EPOR-T is associated with hypertension susceptibility.
    Carruthers SG
    Clin Pharmacol Ther; 2009 Aug; 86(2):134-6. PubMed ID: 19621008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome.
    Jie KE; van der Putten K; Bergevoet MW; Doevendans PA; Gaillard CA; Braam B; Verhaar MC
    Heart; 2011 Jan; 97(1):60-5. PubMed ID: 21071558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin (epoetin) as a protective factor for the brain.
    Malhotra S; Nijhawan S; Rosenbaum DM
    Curr Atheroscler Rep; 2004 Jul; 6(4):301-6. PubMed ID: 15191705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin and organ protection: lessons from negative clinical trials.
    Pearl RG
    Crit Care; 2014 Sep; 18(5):526. PubMed ID: 25672222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke.
    Sobrino T; Rodríguez-González R; Blanco M; Brea D; Pérez-Mato M; Rodríguez-Yáñez M; Leira R; Castillo J
    Neurol Res; 2011 Jul; 33(6):572-7. PubMed ID: 21708065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin in tumor therapy. 10-11 November 2001, Berlin, Germany. Abstracts.
    Onkologie; 2001 Jun; 24 Suppl 3():1-16. PubMed ID: 11475472
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythropoietin in patients with ST-segment elevation myocardial infarction.
    Chen Y
    JAMA; 2011 Aug; 306(7):705-6; author reply 706. PubMed ID: 21846847
    [No Abstract]   [Full Text] [Related]  

  • 12. Darbepoetin alfa and chronic kidney disease.
    Locatelli F; Del Vecchio L; Casartelli D
    N Engl J Med; 2010 Feb; 362(7):654-5; author reply 655. PubMed ID: 20187259
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia.
    Ehrenreich H; Timner W; Sirén AL
    Transfus Apher Sci; 2004 Aug; 31(1):39-44. PubMed ID: 15294194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should patients in intensive care units receive erythropoietin?
    Carson JL
    JAMA; 2002 Dec; 288(22):2884-6. PubMed ID: 12472331
    [No Abstract]   [Full Text] [Related]  

  • 15. Post transplantation anemia: re-emphasizing the use of erythropoietin.
    Jabur WL
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):104-6. PubMed ID: 21196622
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful recombinant erythropoietin therapy for a developing anemic newborn with hereditary spherocytosis.
    Hosono S; Hosono A; Mugishima H; Nakano Y; Minato M; Okada T; Takahashi S; Harada K
    Pediatr Int; 2006 Apr; 48(2):178-80. PubMed ID: 16635181
    [No Abstract]   [Full Text] [Related]  

  • 17. [Should erythropoietin be administered to old patients in the preoperative period of orthopaedics surgery?].
    Páramo Fernández JA
    Med Clin (Barc); 2004 Oct; 123(11):421-2. PubMed ID: 15482717
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical erythropoietin use in patients with cancer: is it time to abandon ship or just drop anchor?
    Tefferi A
    Mayo Clin Proc; 2007 Nov; 82(11):1316-8. PubMed ID: 17976350
    [No Abstract]   [Full Text] [Related]  

  • 19. Forewarned is forearmed: erythropoietin use in CKD patients with cancer.
    Kessler SJ; Bennett CL
    J Nephrol; 2013; 26(5):805-6. PubMed ID: 24052466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Darbepoetin alfa and chronic kidney disease.
    Wright RJ; Kanagasundaram NS; Quinton R
    N Engl J Med; 2010 Feb; 362(7):653; author reply 655. PubMed ID: 20164489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.